| Product NDC: | 55045-3198 | 
| Proprietary Name: | Tamiflu | 
| Non Proprietary Name: | oseltamivir phosphate | 
| Active Ingredient(s): | 12 mg/mL & nbsp; oseltamivir phosphate | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | POWDER, FOR SUSPENSION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 55045-3198 | 
| Labeler Name: | Dispensing Solutions, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA021246 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20001214 | 
| Package NDC: | 55045-3198-2 | 
| Package Description: | 1 BOTTLE, GLASS in 1 BOX (55045-3198-2) > 25 mL in 1 BOTTLE, GLASS | 
| NDC Code | 55045-3198-2 | 
| Proprietary Name | Tamiflu | 
| Package Description | 1 BOTTLE, GLASS in 1 BOX (55045-3198-2) > 25 mL in 1 BOTTLE, GLASS | 
| Product NDC | 55045-3198 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | oseltamivir phosphate | 
| Dosage Form Name | POWDER, FOR SUSPENSION | 
| Route Name | ORAL | 
| Start Marketing Date | 20001214 | 
| Marketing Category Name | NDA | 
| Labeler Name | Dispensing Solutions, Inc. | 
| Substance Name | OSELTAMIVIR PHOSPHATE | 
| Strength Number | 12 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Neuraminidase Inhibitor [EPC],Neuraminidase Inhibitors [MoA] |